Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
Molecules. 2020 Jul 24;25(15):3372. doi: 10.3390/molecules25153372.
The use of virtual drug screening can be beneficial to research teams, enabling them to narrow down potentially useful compounds for further study. A variety of virtual screening methods have been developed, typically with machine learning classifiers at the center of their design. In the present study, we created a virtual screener for protein kinase inhibitors. Experimental compound-target interaction data were obtained from the IDG-DREAM Drug-Kinase Binding Prediction Challenge. These data were converted and fed as inputs into two multi-input recurrent neural networks (RNNs). The first network utilized data encoded in one-hot representation, while the other incorporated embedding layers. The models were developed in Python, and were designed to output the IC of the target compounds. The performance of the models was assessed primarily through analysis of the Q values produced from runs of differing sample and epoch size; recorded loss values were also reported and graphed. The performance of the models was limited, though multiple changes are proposed for potential improvement of a multi-input recurrent neural network-based screening tool.
虚拟药物筛选的使用对于研究团队是有益的,使他们能够缩小潜在有用的化合物,进行进一步的研究。已经开发出了多种虚拟筛选方法,通常以机器学习分类器为设计核心。在本研究中,我们创建了一个用于蛋白激酶抑制剂的虚拟筛选器。实验化合物-靶标相互作用数据来自 IDG-DREAM 药物-激酶结合预测挑战赛。这些数据经过转换并作为输入提供给两个多输入递归神经网络(RNN)。第一个网络使用了独热表示法编码的数据,而另一个则包含了嵌入层。模型是用 Python 开发的,旨在输出目标化合物的 IC。模型的性能主要通过分析不同样本和时期大小的运行产生的 Q 值来评估;还报告和绘制了记录的损失值。尽管提出了多种改进基于多输入递归神经网络的筛选工具的方法,但模型的性能仍然受到限制。